Overall, these data indicated that TM4SF1 may be a potential prognostic marker for predicting metastasis and a target for individualized drug therapy, which may prevent tumour metastasis and improve the prognosis of cancer patients. The gene discussed is TM4SF1; the disease is neoplasm.